Baraclude entecavir: Phase IIIb data

The open-label Phase IIIb ETV-048 study in 191 chronic HBV patients with decompensated cirrhosis showed that Baraclude met the primary

Read the full 201 word article

How to gain access

Continue reading with a
two-week free trial.